Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage

Zhao Lu, Helmut Friess, Hans U. Graber, Xiaozhong Guo, Martin Schilling, Arthur Zimmermann, Murray Korc, Markus W. Büchler

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Transforming growth factor-β (TGF-β) signal transduction is mediated via specific cell surface signaling TGF-β receptors, most notably the type I ALK5 (TβR-I(ALK5)) and the type II (TβR-II). We evaluated TβR-(ALK5) and TβR-II expression in 41 human pancreatic cancer tissue samples and correlated these findings with clinical data of the patients. Northern blot analysis indicated that, in comparison with the normal pancreas, pancreatic adenocarcinomas exhibited 8.0-fold and 4.5-fold increases (P <0.01), respectively, in mRNA levels encoding TβR-I(ALK5) and TβR-II. In situ hybridization showed that both TβR-I(ALK5) and TβR-II mRNA were highly expressed in the majority of pancreatic cancer cells. Immunohistochemical analysis of TβR-I(ALK5) and TβR-II revealed positive immunostaining in 73% and 56% of the tumors, respectively. Both receptors were concomitantly present in 54% of the pancreatic cancer samples. The presence of TβR- I(ALK5) or TβR-II and the concomitant presence of TβR-I(ALK5) and TβR-II in the cancer cells was associated with advanced tumor stage (P <0.01). These findings show that in many human pancreatic cancers, increased levels of the two signaling TβRs are present. The presence of the signaling TβRs in advanced tumor stages indicates a role in disease progression.

Original languageEnglish (US)
Pages (from-to)2054-2063
Number of pages10
JournalDigestive Diseases and Sciences
Volume42
Issue number10
StatePublished - 1997
Externally publishedYes

Fingerprint

Growth Factor Receptors
Transforming Growth Factors
Pancreatic Neoplasms
Neoplasms
Messenger RNA
Northern Blotting
In Situ Hybridization
Disease Progression
Pancreas
Signal Transduction
Adenocarcinoma

Keywords

  • Immunohistochemistry
  • In situ hybridization
  • Northern blot analysis
  • Pancreatic cancer
  • Transforming growth factor-β receptors

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lu, Z., Friess, H., Graber, H. U., Guo, X., Schilling, M., Zimmermann, A., ... Büchler, M. W. (1997). Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. Digestive Diseases and Sciences, 42(10), 2054-2063.

Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. / Lu, Zhao; Friess, Helmut; Graber, Hans U.; Guo, Xiaozhong; Schilling, Martin; Zimmermann, Arthur; Korc, Murray; Büchler, Markus W.

In: Digestive Diseases and Sciences, Vol. 42, No. 10, 1997, p. 2054-2063.

Research output: Contribution to journalArticle

Lu, Z, Friess, H, Graber, HU, Guo, X, Schilling, M, Zimmermann, A, Korc, M & Büchler, MW 1997, 'Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage', Digestive Diseases and Sciences, vol. 42, no. 10, pp. 2054-2063.
Lu Z, Friess H, Graber HU, Guo X, Schilling M, Zimmermann A et al. Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. Digestive Diseases and Sciences. 1997;42(10):2054-2063.
Lu, Zhao ; Friess, Helmut ; Graber, Hans U. ; Guo, Xiaozhong ; Schilling, Martin ; Zimmermann, Arthur ; Korc, Murray ; Büchler, Markus W. / Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage. In: Digestive Diseases and Sciences. 1997 ; Vol. 42, No. 10. pp. 2054-2063.
@article{24a746fa9fd94a45ba14c36acd492f2f,
title = "Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage",
abstract = "Transforming growth factor-β (TGF-β) signal transduction is mediated via specific cell surface signaling TGF-β receptors, most notably the type I ALK5 (TβR-I(ALK5)) and the type II (TβR-II). We evaluated TβR-(ALK5) and TβR-II expression in 41 human pancreatic cancer tissue samples and correlated these findings with clinical data of the patients. Northern blot analysis indicated that, in comparison with the normal pancreas, pancreatic adenocarcinomas exhibited 8.0-fold and 4.5-fold increases (P <0.01), respectively, in mRNA levels encoding TβR-I(ALK5) and TβR-II. In situ hybridization showed that both TβR-I(ALK5) and TβR-II mRNA were highly expressed in the majority of pancreatic cancer cells. Immunohistochemical analysis of TβR-I(ALK5) and TβR-II revealed positive immunostaining in 73{\%} and 56{\%} of the tumors, respectively. Both receptors were concomitantly present in 54{\%} of the pancreatic cancer samples. The presence of TβR- I(ALK5) or TβR-II and the concomitant presence of TβR-I(ALK5) and TβR-II in the cancer cells was associated with advanced tumor stage (P <0.01). These findings show that in many human pancreatic cancers, increased levels of the two signaling TβRs are present. The presence of the signaling TβRs in advanced tumor stages indicates a role in disease progression.",
keywords = "Immunohistochemistry, In situ hybridization, Northern blot analysis, Pancreatic cancer, Transforming growth factor-β receptors",
author = "Zhao Lu and Helmut Friess and Graber, {Hans U.} and Xiaozhong Guo and Martin Schilling and Arthur Zimmermann and Murray Korc and B{\"u}chler, {Markus W.}",
year = "1997",
language = "English (US)",
volume = "42",
pages = "2054--2063",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Presence of two signaling TGF-β receptors in human pancreatic cancer correlates with advanced tumor stage

AU - Lu, Zhao

AU - Friess, Helmut

AU - Graber, Hans U.

AU - Guo, Xiaozhong

AU - Schilling, Martin

AU - Zimmermann, Arthur

AU - Korc, Murray

AU - Büchler, Markus W.

PY - 1997

Y1 - 1997

N2 - Transforming growth factor-β (TGF-β) signal transduction is mediated via specific cell surface signaling TGF-β receptors, most notably the type I ALK5 (TβR-I(ALK5)) and the type II (TβR-II). We evaluated TβR-(ALK5) and TβR-II expression in 41 human pancreatic cancer tissue samples and correlated these findings with clinical data of the patients. Northern blot analysis indicated that, in comparison with the normal pancreas, pancreatic adenocarcinomas exhibited 8.0-fold and 4.5-fold increases (P <0.01), respectively, in mRNA levels encoding TβR-I(ALK5) and TβR-II. In situ hybridization showed that both TβR-I(ALK5) and TβR-II mRNA were highly expressed in the majority of pancreatic cancer cells. Immunohistochemical analysis of TβR-I(ALK5) and TβR-II revealed positive immunostaining in 73% and 56% of the tumors, respectively. Both receptors were concomitantly present in 54% of the pancreatic cancer samples. The presence of TβR- I(ALK5) or TβR-II and the concomitant presence of TβR-I(ALK5) and TβR-II in the cancer cells was associated with advanced tumor stage (P <0.01). These findings show that in many human pancreatic cancers, increased levels of the two signaling TβRs are present. The presence of the signaling TβRs in advanced tumor stages indicates a role in disease progression.

AB - Transforming growth factor-β (TGF-β) signal transduction is mediated via specific cell surface signaling TGF-β receptors, most notably the type I ALK5 (TβR-I(ALK5)) and the type II (TβR-II). We evaluated TβR-(ALK5) and TβR-II expression in 41 human pancreatic cancer tissue samples and correlated these findings with clinical data of the patients. Northern blot analysis indicated that, in comparison with the normal pancreas, pancreatic adenocarcinomas exhibited 8.0-fold and 4.5-fold increases (P <0.01), respectively, in mRNA levels encoding TβR-I(ALK5) and TβR-II. In situ hybridization showed that both TβR-I(ALK5) and TβR-II mRNA were highly expressed in the majority of pancreatic cancer cells. Immunohistochemical analysis of TβR-I(ALK5) and TβR-II revealed positive immunostaining in 73% and 56% of the tumors, respectively. Both receptors were concomitantly present in 54% of the pancreatic cancer samples. The presence of TβR- I(ALK5) or TβR-II and the concomitant presence of TβR-I(ALK5) and TβR-II in the cancer cells was associated with advanced tumor stage (P <0.01). These findings show that in many human pancreatic cancers, increased levels of the two signaling TβRs are present. The presence of the signaling TβRs in advanced tumor stages indicates a role in disease progression.

KW - Immunohistochemistry

KW - In situ hybridization

KW - Northern blot analysis

KW - Pancreatic cancer

KW - Transforming growth factor-β receptors

UR - http://www.scopus.com/inward/record.url?scp=0030827414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030827414&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 2054

EP - 2063

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -